
The National Institute for Health and Care and Excellence (NICE) has approved the use of a new drug to aid weight loss in people suffering from obesity.
The watchdog has issued draft guidance on Tuesday 8 February recommending that adults who have at least one weight-related condition and a body mass index (BMI) of 35 or more, should be prescribed semaglutide as part of a weight-management plan.